155 related articles for article (PubMed ID: 20364539)
21. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
Neaigus A; Zhao M; Gyarmathy VA; Cisek L; Friedman SR; Baxter RC
J Urban Health; 2008 May; 85(3):309-22. PubMed ID: 18340537
[TBL] [Abstract][Full Text] [Related]
22. Incidence of hepatitis C virus infection among injection drug users during an outbreak of HIV infection.
Patrick DM; Tyndall MW; Cornelisse PG; Li K; Sherlock CH; Rekart ML; Strathdee SA; Currie SL; Schechter MT; O'Shaughnessy MV
CMAJ; 2001 Oct; 165(7):889-95. PubMed ID: 11599327
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C virus and HIV seroprevalences, sociodemographic characteristics, behaviors and access to syringes among drug users, a comparison of geographical areas in France, ANRS-Coquelicot 2011 survey.
Weill-Barillet L; Pillonel J; Semaille C; Léon L; Le Strat Y; Pascal X; Barin F; Jauffret-Roustide M
Rev Epidemiol Sante Publique; 2016 Sep; 64(4):301-12. PubMed ID: 26904917
[TBL] [Abstract][Full Text] [Related]
24. Alarming epidemics of human immunodeficiency virus and hepatitis C virus among injection drug users in the northwestern bordering state of Punjab, India: prevalence and correlates.
Panda S; Roy T; Pahari S; Mehraa J; Sharma N; Singh G; Singh J; Joseph F; Singh S; Sharma NM
Int J STD AIDS; 2014 Jul; 25(8):596-606. PubMed ID: 24352120
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study.
Leprêtre A; Ba I; Lacombe K; Maynart M; Toufik A; Ndiaye O; Kane CT; Gozlan J; Tine J; Ndoye I; Raguin G; Girard PM
J Int AIDS Soc; 2015; 18(1):19888. PubMed ID: 26004637
[TBL] [Abstract][Full Text] [Related]
26. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
[TBL] [Abstract][Full Text] [Related]
27. Is the HCV-HIV co-infection prevalence amongst injecting drug users a marker for the level of sexual and injection related HIV transmission?
Vickerman P; Martin NK; Roy A; Beattie T; Jarlais DD; Strathdee S; Wiessing L; Hickman M;
Drug Alcohol Depend; 2013 Sep; 132(1-2):172-81. PubMed ID: 23453261
[TBL] [Abstract][Full Text] [Related]
28. Cross sectional study of factors associated to self-reported blood-borne infections among drug users.
Reyes-Urueña J; Brugal MT; Majo X; Domingo-Salvany A; Caylà JA
BMC Public Health; 2015 Nov; 15():1122. PubMed ID: 26566634
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and correlates of hepatitis C virus infection among street-recruited injection drug users in San Juan, Puerto Rico.
Reyes JC; Colón HM; Robles RR; Rios E; Matos TD; Negrón J; Marrero CA; Calderón JM; Shepard E
J Urban Health; 2006 Nov; 83(6):1105-13. PubMed ID: 17075726
[TBL] [Abstract][Full Text] [Related]
30. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of HIV, HCV, and High-Risk Behaviors for Substance Users in Drop in Centers in Southern Iran.
Salehi A; Naghshvarian M; Marzban M; Bagheri Lankarani K
J Addict Med; 2015; 9(3):181-7. PubMed ID: 25748560
[TBL] [Abstract][Full Text] [Related]
32. Changing seroprevalence of hepatitis C virus infection among HIV-positive patients in Taiwan.
Li CW; Yang CJ; Sun HY; Tsai MS; Lin SP; Lin TY; Cheng CY; Lee YC; Huang YS; Liu CE; Lee YT; Tang HJ; Wang NC; Cheng SH; Ko WC; Hung CC;
PLoS One; 2018; 13(3):e0194149. PubMed ID: 29547628
[TBL] [Abstract][Full Text] [Related]
33. High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey.
Johnston L; Saumtally A; Corceal S; Mahadoo I; Oodally F
Int J Drug Policy; 2011 Jul; 22(4):252-8. PubMed ID: 21700442
[TBL] [Abstract][Full Text] [Related]
34. Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California.
Horyniak D; Wagner KD; Armenta RF; Cuevas-Mota J; Hendrickson E; Garfein RS
Int J Drug Policy; 2017 Sep; 47():9-17. PubMed ID: 28683432
[TBL] [Abstract][Full Text] [Related]
35. Associations between herpes simplex virus type 2 and HCV With HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV.
Des Jarlais DC; Arasteh K; McKnight C; Hagan H; Perlman DC; Semaan S
Am J Public Health; 2011 Jul; 101(7):1277-83. PubMed ID: 21566021
[TBL] [Abstract][Full Text] [Related]
36. [Risk behaviours and seroprevalence to HIV, HBV and HCV in patients of the AIDS information and prevention center in Valencia, Spain].
Alfonso Gil R; Hurtado Navarro I; Espacio Casanovas A; Santos Rubio G; Tomás Dols S
Gac Sanit; 1999; 13(1):16-21. PubMed ID: 10217673
[TBL] [Abstract][Full Text] [Related]
37. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
38. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
Devi KhS; Brajachand N; Singh HL; Singh YM
J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.
Mohsen AH; Murad S; Easterbrook PJ
HIV Med; 2005 May; 6(3):206-15. PubMed ID: 15876288
[TBL] [Abstract][Full Text] [Related]
40. Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) in a Northern Alberta population.
Bowker SL; Soskolne CL; Houston SC; Newman SC; Jhangri GS
Can J Public Health; 2004; 95(3):188-92. PubMed ID: 15191121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
